Company
Headquarters: Istanbul, Türkiye
Employees: 6,574
₺49.43 Billion
TRY as of Jan. 1, 2026
US$1.15 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. operates as a distribution channel between pharmaceutical manufacturers, hospitals, and pharmacies. It also operates a pharmaceutical warehouse. The company was founded in 1958 and is headquartered in Istanbul, Turkey. Selçuk Ecza Deposu Ticaret ve Sanayi A.S. is a subsidiary of Selçuk Ecza Holding A.S.
| Last Financial Reports Date | Sept. 30, 2025 |
| Revenue TTM | ₺132.70 B |
| EBITDA | ₺5.09 B |
| Gross Profit TTM | ₺11.28 B |
| Profit Margin | 0.48% |
| Operating Margin | 1.15% |
| Quarterly Revenue Growth | 6.70% |
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. has the following listings and related stock indices.
Stock: BIST: SELEC wb_incandescent